Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Endotoxin Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Awomoyi, A. A.
Right arrow Articles by Newport, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awomoyi, A. A.
Right arrow Articles by Newport, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Polymorphism in IL1B: IL1B—511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1ß in IFN-{gamma} primed ex-vivo whole blood assay

Agnes A. Awomoyi

Medical Research Council Laboratories, Fajara, Banjul, The Gambia, Department of Microbiology and Immunology, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland, USA, aawomoyi{at}som.umaryland.edu

Manhattan Charurat

Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, Maryland, USA

Arnaud Marchant

Medical Research Council Laboratories, Fajara, Banjul, The Gambia

E. Nancy Miller

Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, UK

Jenefer M. Blackwell

Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, UK

Keith P.W.J. McAdam

Medical Research Council Laboratories, Fajara, Banjul, The Gambia

Melanie J. Newport

Medical Research Council Laboratories, Fajara, Banjul, The Gambia, Department of Medicine, Brighton and Sussex Medical School, Brighton, UK

To determine whether variation in two interleukin 1 family genes (IL1B and interleukin 1 receptor antagonist, IL1RN) is associated with pulmonary tuberculosis (TB), two published polymorphisms at nucleotide positions —511 and +3953 in IL1B and one in the IL1RN 86 bp VNTR were genotyped in 335 smear positive Gambian TB patients, and 298 ethnically matched controls. All individuals were HIV negative. Decreased risk of pulmonary TB was associated with both heterozygosity and homozygosity for the IL1B—511-C allele (OR 0.66, P = 0.027, and OR 0.58, P = 0.015, respectively). Nonetheless, the C allele was present at a frequency of 0.66 in TB cases suggesting that whilst IL-1ß contributes to disease susceptibility, it is not the major factor. There was no association between the IL1B+3953-T/C polymorphism or the 86 bp IL1RN pentallelic repeat and TB in this population. Using an ex-vivo whole blood assay, healthy Gambian individuals who are homozygous for the IL1B—511-T allele failed to exhibit a significant increase in IL-1ß production in response to LPS after IFN-ypriming.

Key Words: IL1B polymorphism • interleukin-1ß • tuberculosis • ex-vivo whole blood assay

Journal of Endotoxin Research, Vol. 11, No. 5, 281-286 (2005)
DOI: 10.1177/09680519050110050401


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?